Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Akita

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|January 5, 1999
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2G Schaefer, R W Akita, M X Sliwkowski
FEBS Letters|April 24, 1999
Binding specificities and affinities of egf domains for ErbB receptorsJ T Jones, R W Akita, M X Sliwkowski
Seminars in Oncology|January 5, 2002
Structural requirements for ErbB2 transactivationE Penuel, G Schaefer, R W Akita, et al.
Cancer Research|June 5, 2001
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4H Lee, R W Akita, M X Sliwkowski, et al.
Cancer Research|May 15, 1991
An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogeneB C Langton, M C Crenshaw, L A Chao, et al.
The Journal of Biological Chemistry|June 13, 1998
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage displayM D Ballinger, J T Jones, J A Lofgren, et al.
Seminars in Oncology|March 10, 2001
A potential role for activated HER-2 in prostate cancerD B Agus, R W Akita, W D Fox, et al.
Science (New York, N.Y.)|May 22, 1992
Identification of heregulin, a specific activator of p185erbB2W E Holmes, M X Sliwkowski, R W Akita, et al.
The Journal of Biological Chemistry|May 20, 1994
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulinM X Sliwkowski, G Schaefer, R W Akita, et al.
Oncogene|November 11, 1999
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsZ Aguilar, R W Akita, R S Finn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|January 5, 1999
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2G Schaefer, R W Akita, M X Sliwkowski
FEBS Letters|April 24, 1999
Binding specificities and affinities of egf domains for ErbB receptorsJ T Jones, R W Akita, M X Sliwkowski
Seminars in Oncology|January 5, 2002
Structural requirements for ErbB2 transactivationE Penuel, G Schaefer, R W Akita, et al.
Cancer Research|June 5, 2001
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4H Lee, R W Akita, M X Sliwkowski, et al.
Cancer Research|May 15, 1991
An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogeneB C Langton, M C Crenshaw, L A Chao, et al.
The Journal of Biological Chemistry|June 13, 1998
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage displayM D Ballinger, J T Jones, J A Lofgren, et al.
Seminars in Oncology|March 10, 2001
A potential role for activated HER-2 in prostate cancerD B Agus, R W Akita, W D Fox, et al.
Science (New York, N.Y.)|May 22, 1992
Identification of heregulin, a specific activator of p185erbB2W E Holmes, M X Sliwkowski, R W Akita, et al.
The Journal of Biological Chemistry|May 20, 1994
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulinM X Sliwkowski, G Schaefer, R W Akita, et al.
Oncogene|November 11, 1999
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsZ Aguilar, R W Akita, R S Finn, et al.
Pageof 2